{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:05:55Z","timestamp":1757621155309,"version":"3.44.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"2020 Henan science and technology project","award":["LHG20200424"],"award-info":[{"award-number":["LHG20200424"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03302-8","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T11:26:12Z","timestamp":1754133972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lysosome-derived biomarkers for predicting survival outcome in acute myeloid leukemia"],"prefix":"10.1007","volume":"16","author":[{"given":"Gongchang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"issue":"4","key":"3302_CR1","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, B\u00fcchner T, Dombret H, Ebert BL, Fenaux P, Larson RA, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424\u201347.","journal-title":"Blood"},{"issue":"4","key":"3302_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41409-018-0286-2","volume":"54","author":"CJ Lee","year":"2019","unstructured":"Lee CJ, Savani BN, Mohty M, Gorin NC, Labopin M, Ruggeri A, Schmid C, Baron F, Esteve J, Giebel S, et al. Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the acute leukemia working party of the European society for blood and marrow transplantation. Bone Marrow Transplant. 2019;54(4):519\u201330.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"3302_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40035-020-00196-0","volume":"9","author":"Q Song","year":"2020","unstructured":"Song Q, Meng B, Xu H, Mao Z. The emerging roles of vacuolar-type ATPase-dependent lysosomal acidification in neurodegenerative diseases. Translational Neurodegeneration. 2020;9(1):17.","journal-title":"Translational Neurodegeneration"},{"issue":"4","key":"3302_CR4","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1111\/brv.12515","volume":"94","author":"KK Mahapatra","year":"2019","unstructured":"Mahapatra KK, Panigrahi DP, Praharaj PP, Bhol CS, Patra S, Mishra SR, Behera BP, Bhutia SK. Molecular interplay of autophagy and endocytosis in human health and diseases. Biol Rev Camb Philos Soc. 2019;94(4):1576\u201390.","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"2","key":"3302_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41580-019-0185-4","volume":"21","author":"A Ballabio","year":"2020","unstructured":"Ballabio A, Bonifacino JS. Lysosomes as dynamic regulators of cell and organismal homeostasis. Nat Rev Mol Cell Biol. 2020;21(2):101\u201318.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"3302_CR6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41565-020-0639-z","volume":"15","author":"J Qiu","year":"2020","unstructured":"Qiu J, Xia Y. Killing cancer cells by rupturing their lysosomes. Nat Nanotechnol. 2020;15(4):252\u20133.","journal-title":"Nat Nanotechnol"},{"issue":"3","key":"3302_CR7","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1158\/0008-5472.CAN-14-2211","volume":"75","author":"JJ Kamphorst","year":"2015","unstructured":"Kamphorst JJ, Nofal M, Commisso C, Hackett SR, Lu W, Grabocka E, Vander Heiden MG, Miller G, Drebin JA, Bar-Sagi D, et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res. 2015;75(3):544\u201353.","journal-title":"Cancer Res"},{"key":"3302_CR8","doi-asserted-by":"crossref","unstructured":"Vidak E, Javor\u0161ek U, Vizovi\u0161ek M, Turk B. Cysteine cathepsins and their extracellular roles: shaping the microenvironment. Cells. 2019;8(3).","DOI":"10.3390\/cells8030264"},{"key":"3302_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canlet.2018.08.029","volume":"439","author":"X Zhang","year":"2018","unstructured":"Zhang X, Wang J, Li X, Wang D. Lysosomes contribute to radioresistance in cancer. Cancer Lett. 2018;439:39\u201346.","journal-title":"Cancer Lett"},{"issue":"1","key":"3302_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13045-021-01087-1","volume":"14","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Yue P, Lu T, Wang Y, Wei Y, Wei X. Role of lysosomes in physiological activities, diseases, and therapy. J Hematol Oncol. 2021;14(1):79.","journal-title":"J Hematol Oncol"},{"key":"3302_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2147\/JHC.S363200","volume":"9","author":"G Zhang","year":"2022","unstructured":"Zhang G. Platelet-Related molecular subtype to predict prognosis in hepatocellular carcinoma. J Hepatocellular Carcinoma. 2022;9:423\u201336.","journal-title":"J Hepatocellular Carcinoma"},{"key":"3302_CR12","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, Trevi\u00f1o V, Shen H, Laird PW, Levine DA, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"issue":"8","key":"3302_CR13","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.3909","volume":"21","author":"AJ Gentles","year":"2015","unstructured":"Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD, et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med. 2015;21(8):938\u201345.","journal-title":"Nat Med"},{"issue":"1","key":"3302_CR14","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220.","journal-title":"Genome Biol"},{"issue":"1","key":"3302_CR15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12944-021-01554-1","volume":"20","author":"K Zhu","year":"2021","unstructured":"Zhu K, Xiaoqiang L, Deng W, Wang G, Fu B. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer. Lipids Health Dis. 2021;20(1):146.","journal-title":"Lipids Health Dis"},{"issue":"14","key":"3302_CR16","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1158\/0008-5472.CAN-12-1370","volume":"72","author":"WC Reinhold","year":"2012","unstructured":"Reinhold WC, Sunshine M, Liu H, Varma S, Kohn KW, Morris J, Doroshow J, Pommier Y. CellMiner: a web-based suite of genomic and Pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res. 2012;72(14):3499\u2013511.","journal-title":"Cancer Res"},{"key":"3302_CR17","doi-asserted-by":"publisher","first-page":"975762","DOI":"10.3389\/fimmu.2022.975762","volume":"13","author":"G Zhang","year":"2022","unstructured":"Zhang G. Regulatory T-cells-related signature for identifying a prognostic subtype of hepatocellular carcinoma with an exhausted tumor microenvironment. Front Immunol. 2022;13:975762.","journal-title":"Front Immunol"},{"issue":"W1","key":"3302_CR18","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98\u2013102.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3302_CR19","doi-asserted-by":"publisher","first-page":"2305852","DOI":"10.1080\/14756366.2024.2305852","volume":"39","author":"Z Chen","year":"2024","unstructured":"Chen Z, Wang Q, Yan YY, Jin D, Wang Y, Zhang XX, Liu XH. Discovery of novel and potent CDK8 inhibitors for the treatment of acute myeloid leukaemia. J Enzyme Inhib Med Chem. 2024;39(1):2305852.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"3302_CR20","first-page":"311","volume":"34","author":"E Quartin","year":"2024","unstructured":"Quartin E, Rosa S, Gonzalez-Anton S, Mosteo Lopez L, Francisco V, Duarte D, Lo Celso C, Pires das Neves R, Ferreira L. Nanoparticle-encapsulated retinoic acid for the modulation of bone marrow hematopoietic stem cell niche. Bioact Mater. 2024;34:311\u201325.","journal-title":"Bioact Mater"},{"key":"3302_CR21","doi-asserted-by":"publisher","first-page":"105768","DOI":"10.1016\/j.tiv.2023.105768","volume":"96","author":"CJ Teng","year":"2024","unstructured":"Teng CJ, Cheng PT, Cheng YC, Tsai JR, Chen MC, Lin H. Dinaciclib inhibits the growth of acute myeloid leukemia cells through either cell cycle-related or ERK1\/STAT3\/MYC pathways. Toxicol Vitro. 2024;96:105768.","journal-title":"Toxicol Vitro"},{"key":"3302_CR22","doi-asserted-by":"crossref","unstructured":"Modak RV, de Oliveira Rebola KG, McClatchy J, Mohammadhosseini M, Damnernsawad A, Kurtz SE, Eide CA, Wu G, Laderas T, Nechiporuk T et al. Targeting CCL2\/CCR2 signaling overcomes MEK inhibitor resistance in acute myeloid leukemia. Clin Cancer Res. 2024.","DOI":"10.1158\/1078-0432.c.7234862.v1"},{"key":"3302_CR23","doi-asserted-by":"crossref","unstructured":"Cieniewicz B, Oliveira E, Saxton M, Torabi D, Bhatta A, Kukutla P, Arballo A, Yang Z, Yu B, Fate M et al. Therapeutic targeting of TIM-4-L with engineered T cells for acute myeloid leukemia. Clin Cancer Res. 2024.","DOI":"10.1158\/1078-0432.c.7209088"},{"key":"3302_CR24","doi-asserted-by":"crossref","unstructured":"Ciurea SO, Kongtim P, Srour S, Chen J, Soebbing D, Shpall E, Rezvani K, Nakkula R, Thakkar A, Troy EC et al. Results of a phase I trial with haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML. Am J Hematol. 2024.","DOI":"10.1002\/ajh.27281"},{"issue":"1","key":"3302_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40164-024-00483-w","volume":"13","author":"AR Marr","year":"2024","unstructured":"Marr AR, Halpin M, Corbin DL, Asemelash Y, Sher S, Gordon BK, Whipp EC, Mitchell S, Harrington BK, Orwick S, et al. The multi-CDK inhibitor Dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via Inhibition of Wnt\/\u03b2-catenin signaling. Exp Hematol Oncol. 2024;13(1):27.","journal-title":"Exp Hematol Oncol"},{"key":"3302_CR26","doi-asserted-by":"publisher","first-page":"105335","DOI":"10.1016\/j.phrs.2020.105335","volume":"164","author":"S Zhang","year":"2021","unstructured":"Zhang S, Liu M, Yao Y, Yu B, Liu H. Targeting LSD1 for acute myeloid leukemia (AML) treatment. Pharmacol Res. 2021;164:105335.","journal-title":"Pharmacol Res"},{"issue":"1","key":"3302_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1021\/acsomega.1c04771","volume":"7","author":"B Mondal","year":"2022","unstructured":"Mondal B, Dutta T, Padhy A, Das S, Sen Gupta S. Lysosome-Targeting strategy using polypeptides and chimeric molecules. ACS Omega. 2022;7(1):5\u201316.","journal-title":"ACS Omega"},{"key":"3302_CR28","doi-asserted-by":"publisher","first-page":"101495","DOI":"10.1016\/j.redox.2020.101495","volume":"32","author":"N Wang","year":"2020","unstructured":"Wang N, Liu H, Liu G, Li M, He X, Yin C, Tu Q, Shen X, Bai W, Wang Q, et al. Yeast \u03b2-D-glucan exerts antitumour activity in liver cancer through impairing autophagy and lysosomal function, promoting reactive oxygen species production and apoptosis. Redox Biol. 2020;32:101495.","journal-title":"Redox Biol"},{"key":"3302_CR29","doi-asserted-by":"publisher","first-page":"1170397","DOI":"10.3389\/fonc.2023.1170397","volume":"13","author":"H Zhang","year":"2023","unstructured":"Zhang H, Liu D, Qin Z, Yi B, Zhu L, Xu S, Wang K, Yang S, Liu R, Yang K, et al. CHMP4C as a novel marker regulates prostate cancer progression through cycle pathways and contributes to immunotherapy. Front Oncol. 2023;13:1170397.","journal-title":"Front Oncol"},{"key":"3302_CR30","doi-asserted-by":"publisher","first-page":"1196802","DOI":"10.3389\/fonc.2023.1196802","volume":"13","author":"Y Xue","year":"2023","unstructured":"Xue Y, Zhao G, Pu X, Jiao F. Construction of T cell exhaustion model for predicting survival and immunotherapy effect of bladder cancer based on WGCNA. Front Oncol. 2023;13:1196802.","journal-title":"Front Oncol"},{"issue":"1","key":"3302_CR31","doi-asserted-by":"publisher","first-page":"21467","DOI":"10.1038\/s41598-022-26110-4","volume":"12","author":"T Wu","year":"2022","unstructured":"Wu T, Li S, Yu C, Wu Y, Long H. A risk model based on pyroptosis subtypes predicts tumor immune microenvironment and guides chemotherapy and immunotherapy in bladder cancer. Sci Rep. 2022;12(1):21467.","journal-title":"Sci Rep"},{"issue":"2","key":"3302_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41429-023-00683-2","volume":"77","author":"X Jin","year":"2024","unstructured":"Jin X, Wang J, Wang Z, Pang W, Chen Y, Yang L. Chromatin-modifying protein 4\u00a0C (CHMP4C) affects breast cancer cell growth and doxorubicin resistance as a potential breast cancer therapeutic target. J Antibiot (Tokyo). 2024;77(2):93\u2013101.","journal-title":"J Antibiot (Tokyo)"},{"issue":"18","key":"3302_CR33","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. Cancer Res. 2019;79(18):4557\u201366.","journal-title":"Cancer Res"},{"key":"3302_CR34","doi-asserted-by":"crossref","unstructured":"Brauneck F, Fischer B, Witt M, Muschhammer J, Oelrich J, da Costa Avelar PH, Tsoka S, Bullinger L, Seubert E, Smit DJ et al. TIGIT Blockade repolarizes AML-associated TIGIT(+) M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis. J Immunother Cancer. 2022;10(12).","DOI":"10.1136\/jitc-2022-004794"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03302-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03302-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03302-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T12:13:18Z","timestamp":1757333598000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03302-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,2]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3302"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03302-8","relation":{},"ISSN":["2730-6011"],"issn-type":[{"type":"electronic","value":"2730-6011"}],"subject":[],"published":{"date-parts":[[2025,8,2]]},"assertion":[{"value":"23 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was supported by the Ethics Committees of Zhengzhou University (2022-KY-0631-002). Written informed consent was obtained from all patients. All methods were performed following the relevant guidelines and regulations. The manuscript is consistent with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1455"}}